A new not-for-profit company will manufacture important generics in the US

A new comedy series focuses on pharma and a clinical trial gone wrong.

After many years of clinical trial failures in Alzheimer’s disease, pharma sees some positive results – although caution is recommended.

Women, like men, want good medicines that have been tested in clinical trials involving fair representation of both sexes.

We examine the most commercially important biotherapeutics now, and in the future.

Making cancer drugs cheaper and more effective – with a paper “coffee” filter.

What is the current state of pharma contract development and manufacturing?

No dinosaurs were harmed in the making of this vaccine…

Nominations for the 2018 Innovation Awards are open!

Biosimilars had their big break in the US in 2015, but three years later biosimilars are still struggling to make a mark.